scorecardresearchAbbott India Share Price Live NSE, BSE, Today - Abbott India Stock Price
Mintgenie
Asian Paints3,148.000.35 (0.01%)
Axis Bank1,060.4040.00 (3.92%)
Bajaj Finance7,129.753.60 (0.05%)
Bajaj Finserve1,649.00-5.55 (-0.34%)
Bharti Airtel994.859.30 (0.94%)
HCL Technologies1,333.6016.80 (1.28%)
HDFC Bank1,559.2529.65 (1.94%)
Hindustan Unilever2,524.0512.80 (0.51%)
ICICI Bank939.3513.30 (1.44%)
ITC437.252.00 (0.46%)
Indusind Bank1,486.008.20 (0.55%)
Infosys1,459.1016.05 (1.11%)
Kotak Mahindra Bank1,758.4517.40 (1.00%)
Larsen & Toubro3,080.0530.10 (0.99%)
Mahindra & Mahindra1,618.9052.95 (3.38%)
Maruti Suzuki India10,558.0020.85 (0.20%)
NTPC258.400.80 (0.31%)
Nestle India24,071.95-137.00 (-0.57%)
Power Grid Corporation Of India211.100.95 (0.45%)
Reliance Industries2,400.505.95 (0.25%)
State Bank Of India568.503.95 (0.70%)
Sun Pharmaceutical Industries1,200.859.45 (0.79%)
Tata Consultancy Services3,513.1042.65 (1.23%)
Tata Motors712.1514.55 (2.09%)
Tata Steel127.700.85 (0.67%)
Tech Mahindra1,221.4518.20 (1.51%)
Titan Company3,425.05-17.00 (-0.49%)
Ultratech Cement8,721.80-6.20 (-0.07%)
Wipro406.159.20 (2.32%)

Abbott India

BSE: 500488 | NSE: ABBOTINDIA | ISIN: INE358A01014 | SECTOR: Biotechnology & Drugs

₹23,500.00 -192.75 (-0.81%)

29 Nov 2023, 09:59 (IST)

  • Open

    23,749.15

  • High

    23,749.15

  • Low

    23,500.00

  • Prev Close

    23,692.75

  • P/E

    -

  • Median P/E

    -

  • P/B

    -

  • Median P/B

    -

  • Market Cap

    499.36B

  • Volume

    0.18K

  • Vol. (20 day Avg.)

    0

  • PEG

    -

  • Div.Yield

    -

  • Bid

    -

  • Ask

    -
View all metrics

Company Description

  • Biotechnology & Drugs

  • BSE

    500488

  • NSE

    ABBOTINDIA

  • ISIN

    INE358A01014

Abbott India Limited is an India-based company that is engaged in the pharmaceuticals business. The Company has a portfolio of offerings in diagnostics, medical devices, nutrition products and branded generic medicines. It provides products and solutions across various therapeutic areas, such as women's health, gastroenterology, central nervous system, metabolic, multi-specialty, and vaccines, among others. Its products include Colospa (irritable bowel disease), Ganaton (gastrointestinal motility), Librax (irritable bowel disease), Zolfresh (insomnia), Thyronorm (hypothyroidism), Duphaston (miscarriage and IVF), Duphalac (constipation), Digene (antacid), Prothiaden (pain and depression), Influvac (prevention of influenza), Creon (pancreatic insufficiency), Cremaffin Plus (Constipation), Pankreoflat (indigestion), Brufen P (fever), Duvadilan (preterm labor), and others. It offers various products under brands, such as Similac, PediaSure, Pedialyte, EleCare, Ensure, Glucerna, and others.

Company Officers

  • Sridhar Kadangode

    Chief Financial Officer

  • Sangeeta Shetty

    Chief Compliance Officer, Company Secretary

  • Vivek Kamath

    Managing Director, Executive Director

  • Kunal Chowdhury

    Commercial Director - GI Business

  • Rajan Kalantre

    Director - Business Human Resources

  • Jejoe Karankumar

    Director - Medical Affairs

  • Sandeep Reddy

    Commercial Director - Women's Health, Metabolics & International Business

  • Ashok Saini

    Commercial Director - GenNext, Vaccine and Neurolife

  • Namita Shah

    Associate Director - New Product Introductions and Therapy Area Strategy

  • Richa Tripathi

    Associate Director - Sales Force Effectiveness, Project Management Officer